Saturday, July 26, 2014





Study: Aging US to strain cancer care

As more baby boomers are diagnosed, doctors, treatments may be stretched thin


September 11. 2013 12:10AM
LAURAN NEERGAARD AP Medical Writer

Story Tools
PrintPrint | E-MailEMail | SaveSave | Hear Generate QR Code QR
Send to Kindle


WASHINGTON — The U.S. is facing a crisis in how to deliver cancer care, as the baby boomers reach their tumor-prone years and doctors have a hard time keeping up with complex new treatments, government advisers reported Tuesday.


The caution comes even as scientists are learning more than ever about better ways to battle cancer, and developing innovative therapies to target tumors.


And while doctors try to optimize treatment, the Institute of Medicine found “daunting” barriers to achieving high-quality care for all patients. Overcoming those challenges will require changes to the health care system, and savvier consumers.


“We do not want to frighten or scare people who are getting care now,” said Dr. Patricia Ganz, a cancer specialist at the University of California, Los Angeles, who chaired the panel.


But too often, decisions about cancer treatments aren’t based on good evidence, and patients may not understand their choices and what to expect, the panel found. For example, some studies suggest that two-thirds or more of cancer patients with poor prognoses incorrectly believe the treatments they receive could cure them.


Topping the list of recommendations is finding ways to help patients make more informed decisions, with easy-to-understand information on the pros, cons and costs of different treatments.


“The patient can’t be passive,” Ganz said. “It’s an important partnership that we need.”


The risk of cancer increases with age, and older adults account for just over half of the 1.6 million new cases diagnosed each year. By 2030, new diagnoses are expected to reach 2.3 million a year as the population ages. The report warns there may not be enough oncology specialists to care for them.


Perhaps a bigger concern is the growing complexity of care. Increasingly, scientists are finding genetic differences inside tumors that help explain why one person’s cancer is more aggressive than another’s. More important, that also means certain cancer drugs will work for, say, lung cancer in one person but not the next.


“If your doctor doesn’t know that, or your hospital doesn’t do the test, you don’t have that opportunity” for newer, targeted therapies, Ganz said. But, “we are living in an information age where it’s impossible to keep up.”


It’s not just a matter of knowing the latest treatments, but deciding if they’re worth it for an individual patient. Consider: Of 13 cancer treatments approved by the Food and Drug Administration last year, only one was proven to extend survival by more than a median of six months, the report said. The drugs all cost more than $5,900 for each month of treatment.


For older adults, treatment decisions may be even more complicated — because the studies that test different therapies don’t include enough people over age 65, who tend to have multiple health problems along with cancer, Ganz explained.




Comments
comments powered by Disqus Commenting Guidelines
Poll
Mortgage Minute


Search for New & Used Cars

Make 
Model
 
Used New All
 

Search Times Leader Classifieds to find just the home you want!

Search Times Leader Classifieds to find just what you need!

Search Pet Classifieds
Dogs Cats Other Animals



Social Media/RSS
Times Leader on Twitter
Times Leader on Youtube
Times Leader on Google+
The Times Leader on Tumblr
The Times Leader on Pinterest
Times Leader RSS Feeds